about
Guanine nucleotide-binding proteins involved in transmembrane signaling.Genetic sequences that predispose to retinoblastoma and osteosarcoma.Tumor cell hybridization and neoplastic progression.The role of phosphoinositides in cell physiology.Phosphatidylinositol kinases and cell transformation.Mechanism of regulation of protein kinase C by lipid second messengers.Chromosomal approaches to the molecular basis of neoplasia.Cellular and molecular mechanisms of carcinogenesis in lining epithelia.Critical genetic determinants and molecular events in multistage skin carcinogenesis.Role of oncogenes and tumor suppressor genes in a multistep model of carcinogenesis.Retroviruses as tools for mammalian development.Proto-oncogene expression and growth factors during liver regeneration.Biological activity in vivo and in vitro of pituitary and brain fibroblast growth factor.The human interferons: from the past and into the future.Modulation of gene expression during terminal cell differentiation: murine erythroleukemia.The spectrum of human lung cancer cells in culture: a potential model for studying molecular determinants of tumor progression and metastasis.Possible mechanisms of interferon-induced growth inhibition.Nerve growth factor: mechanism of action.Prostaglandins and metastasis.Proteases, angiogenesis, and invasion.Angiogenesis: initiation and modulation.An introduction to cancer invasion and metastasis.Metastatic cell attachment to and invasion of vascular endothelium and its underlying basal lamina using endothelial cell monolayers.Mammary tumor heterogeneity.Interactions between tumor cell subpopulations in malignant tumors.Heterogeneity in human colon cancer.The interdependence of laboratory and clinical research in the study of metastases.Host-mediated mechanisms in the elimination of circulating cancer cells.Role of natural killer cells in host defense against cancer metastasis.Conditioning of tissues for metastasis formation by radiation and cytotoxic drugs.On the immunogenicity of tumor cells and the pattern of metastasis.Anticoagulants and tumor growth: pharmacological considerations.Role of prostacyclin as a natural deterrent to hematogenous tumor metastasis.Concepts for the treatment of tumor metastasis.Chemotherapy for metastatic disease.The role of radiation therapy in the curative treatment of metastatic disease.The generation of tumoricidal activity in macrophages for the treatment of established metastases.Monoclonal antibody 791T/36 for tumor detection and therapy for metastases.Relevance of spontaneous in vivo tumor-host cell fusion to tumor progression and metastasis evaluated using a series of lectin-resistant mutant tumor sublines.The Ernst W. Bertner Memorial Award lecture: the evolution of biological heterogeneity in metastatic neoplasms.
P1433
Q36432688-93F02B95-0525-4216-BD9C-7094BFC28122Q36459557-222B4C41-9FD9-4EE8-8837-FB06089D018CQ38583508-E59D1515-9296-460F-9929-31A829B1E879Q39168324-40FD1DA5-5B91-49EB-B0F8-71B21228F17CQ39168331-26F87D35-FC3F-449E-8BE1-00C768EC7C08Q39688246-9EB51B05-DEB0-4036-8E10-1632E5E38748Q39688251-CB637AF1-7F4C-4C99-B074-94B53A337292Q39688257-790831C4-6C7F-4EBB-94E6-9F24214BE3BBQ39688261-D64A2B6C-507E-4C6B-A945-2090C285B0EEQ39688268-864639A7-6C10-49F9-AF1D-46D634501F24Q39688272-102B04D5-DFE5-467B-B883-38CF5AB19B09Q39688278-11D43E20-189D-4DAF-AAC2-E404A86B2B60Q40075972-D35832B4-FB4B-4C15-AAED-757B0C2283FAQ40075976-488970B9-D434-4575-8A9F-86D87B1E4C51Q40075983-0D9B295D-0D8B-4F7D-B756-D853C0A39A1CQ40077593-3E5DC214-C9EA-43B4-B05F-CA69BC080BC6Q40080267-56E040B6-8C11-4E7A-B3B5-966A504C12BEQ40080274-D1E427EF-E06C-463D-97DF-CECE46089C09Q40111340-B7474E31-C421-48E4-9E08-2A9CDA7679C0Q40111346-37D5BEC7-DA12-4255-9426-ACC2CC853E9AQ40111350-19EB4B20-5152-4863-9AC9-4BC4268AC149Q40185761-E57E24EE-6653-41CD-9CD8-95FB9CE9ABACQ40185770-5C10C91B-43C1-4839-8267-01EDB48D2A1CQ40185775-62DF6851-72C1-44DA-B730-A579232F1EA5Q40185781-3A4571E0-61F2-4675-89A3-C93FEA489370Q40185786-53470ED6-D5BE-4A6F-BFAB-F2C5F7C8106FQ40185790-F209AA6F-DDEC-4938-BDE1-E91F3AABA457Q40185796-6C314044-1FCB-44DC-B172-9163FCFE26F6Q40185800-37876D11-2A46-40C5-BDB5-FEA8EDFA2460Q40185805-797BC79D-22E7-4419-A6E6-E4114CE4EB36Q40185811-63E50A0D-5AEC-46E8-AA41-4B17C6DBC3AEQ40185816-62C510FB-459D-42EA-9F1A-79E02E67C11CQ40185820-EF4207E2-3A1B-4B39-9147-C341CEEF732BQ40185825-B0F1AA39-41F4-4C79-AFB4-FC5E52322797Q40185832-7312636D-3099-4551-A7B6-8C7E4D665DD3Q40185838-D7E0B2E3-3E24-4130-B4B3-2A9B7F839F7EQ40185844-50573CD9-214F-4E3E-8DD0-5148DD6870EBQ40185850-08E888A0-4BCA-45DB-8C58-3A45EF952D64Q40185858-5B10AC54-20E6-415F-A3B0-03261E1A4FCDQ40185863-E4A5E88F-7109-45BE-A538-5F89E909566F
P1433
description
journal
@en
revista científica
@es
rivista scientifica
@it
wetenschappelijk tijdschrift
@nl
wissenschaftliche Fachzeitschrift
@de
name
Symposium on Fundamental Cancer Research
@ast
Symposium on Fundamental Cancer Research
@en
Symposium on Fundamental Cancer Research
@es
Symposium on Fundamental Cancer Research
@it
Symposium on Fundamental Cancer Research
@nl
type
label
Symposium on Fundamental Cancer Research
@ast
Symposium on Fundamental Cancer Research
@en
Symposium on Fundamental Cancer Research
@es
Symposium on Fundamental Cancer Research
@it
Symposium on Fundamental Cancer Research
@nl
altLabel
Symp Fundam Cancer Res
@en
prefLabel
Symposium on Fundamental Cancer Research
@ast
Symposium on Fundamental Cancer Research
@en
Symposium on Fundamental Cancer Research
@es
Symposium on Fundamental Cancer Research
@it
Symposium on Fundamental Cancer Research
@nl
P214
P244
P1055
P1476
Symposium on Fundamental Cancer Research
@en
P214
P236
P244
P6981
P7859
lccn-n80120830